Close
ACHEMA MIDDLE EAST 2026

CDMO Growth and Biotechnology Outsourcing Trends

Since many contract manufacturing companies (CMOs) are the only ones able to produce the vast quantities of medications and treatments required, outsourcing has grown...

Growth of Clinical Trials in Emerging Markets and its Impact on Pharma Supply Chains

Emerging markets—encompassing Asia-Pacific, Latin America, and the Middle East—have emerged as increasingly important centers for clinical research and drug development. This geographic shift reflects...

Singapore’s Emergence as a Pharma Manufacturing & Logistics Powerhouse

Singapore has transformed from a modest manufacturing location into Asia’s preeminent pharmaceutical and biopharmaceutical hub, attracting extraordinary investments from global pharmaceutical leaders while establishing...

The Pharmaceutical Industry’s Shift Toward Advanced Clinical Supply Solutions

Modern clinical trial supply chains have evolved dramatically from straightforward logistics operations to sophisticated, technology-enabled systems that integrate advanced analytics, real-time inventory visibility, adaptive...

The Next Wave of Biomanufacturing Facilities: Automation, Digitization and Sustainability

Modern biomanufacturing facilities represent the convergence of advanced automation, sophisticated digital systems, and environmental stewardship principles. Next-generation facilities fundamentally differ from traditional pharmaceutical plants...

Surge in CDMO Expansion: Why Pharma Companies are Increasing Outsourcing

The contract development and manufacturing organization (CDMO) sector is experiencing unprecedented growth as pharmaceutical companies fundamentally reassess their manufacturing strategies. Once viewed as a...

Biopharmaceutical Manufacturing Growth: Capacity, Technology and Workforce Trends

The biopharmaceutical manufacturing sector stands at a pivotal juncture, driven by unprecedented demand for biologics, biosimilars, and advanced therapeutic modalities. As the global biosimilar...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...